A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
Background The benefit of pharmacogenetic testing before starting drug therapy has been
well documented for several single gene–drug combinations. However, the clinical utility of a …
well documented for several single gene–drug combinations. However, the clinical utility of a …
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal …
Statins reduce cholesterol, prevent cardiovascular disease, and are among the most
commonly prescribed medications in the world. Statin‐associated musculoskeletal symptoms (…
commonly prescribed medications in the world. Statin‐associated musculoskeletal symptoms (…
[HTML][HTML] A Review of the Important Role of CYP2D6 in Pharmacogenomics
…, V Yip, P Maguire, M Pirmohamed, RM Turner - Genes, 2020 - mdpi.com
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of ~20%
of commonly used drugs across a broad spectrum of medical disciplines including …
of commonly used drugs across a broad spectrum of medical disciplines including …
Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta‐analysis
RM Turner, CS Kwok, C Chen‐Turner… - British journal of …, 2014 - Wiley Online Library
Aims To determine whether thiazolidinedione use is associated with a risk of bladder cancer.
Methods We searched MEDLINE and EMBASE in J une 2012 (with P ub M ed update to J …
Methods We searched MEDLINE and EMBASE in J une 2012 (with P ub M ed update to J …
Continuous flow reaction monitoring using an on‐line miniature mass spectrometer
…, S Dunnage, IR Baxendale, RM Turner… - Rapid …, 2012 - Wiley Online Library
RATIONALE A recently developed miniature electrospray ionisation mass spectrometer has
been coupled to a preparative flow chemistry system in order to monitor reactive …
been coupled to a preparative flow chemistry system in order to monitor reactive …
Flow chemistry meets advanced functional materials
RM Myers, DE Fitzpatrick, RM Turner… - Chemistry–A European …, 2014 - Wiley Online Library
Flow chemistry and continuous processing techniques are beginning to have a profound
impact on the production of functional materials ranging from quantum dots, nanoparticles and …
impact on the production of functional materials ranging from quantum dots, nanoparticles and …
A self-organizing chemical assembly line
AG Salles Jr, S Zarra, RM Turner… - Journal of the American …, 2013 - ACS Publications
Chemical syntheses generally involve a series of discrete transformations whereby a simple
set of starting materials are progressively rendered more complex. In contrast, living …
set of starting materials are progressively rendered more complex. In contrast, living …
Parsing interindividual drug variability: an emerging role for systems pharmacology
RM Turner, BK Park… - … Reviews: Systems Biology …, 2015 - Wiley Online Library
There is notable interindividual heterogeneity in drug response, affecting both drug efficacy
and toxicity, resulting in patient harm and the inefficient utilization of limited healthcare …
and toxicity, resulting in patient harm and the inefficient utilization of limited healthcare …
[HTML][HTML] Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries
…, G Sunder-Plassmann, RM Turner, M Pirmohamed… - PloS one, 2022 - journals.plos.org
Background The clinical implementation of pharmacogenomics (PGx) could be one of the
first milestones towards realizing personalized medicine in routine care. However, its …
first milestones towards realizing personalized medicine in routine care. However, its …
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on …
EF Magavern, JC Kaski, RM Turner… - European Heart …, 2022 - academic.oup.com
There is a strong and ever-growing body of evidence regarding the use of pharmacogenomics
to inform cardiovascular pharmacology. However, there is no common position taken by …
to inform cardiovascular pharmacology. However, there is no common position taken by …